That last list is the "503A bulks list." Appearing on it is a compounding-eligibility decision it is not FDA approval of a finished drug, which is an entirely separate pathway
Patients report average weight loss of 15-20% of body weight, waist reductions of up to six inches, and a 93% success rate in maintaining results beyond six months
Schedule a consultation to discuss Semaglutide, Tirzepatide, oral options, labs, and ongoing support
In the widely used forced swim test, which measures behavioral despair, mice on a CR diet showed less immobility - suggesting a potential antidepressant-like effect ( While encouraging, the observed findings come with several important limitations
Vague dosing instructions or a lack of transparency from the manufacturer should also raise concern
The reason for this wait, also called a deferral period, is because CSL is mandated to comply with various global regulatory requirements